Stansberry Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Stansberry Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,472	Closed	-$840K	–	113
2023 Q3	$840K	Sell	14,472 -87,585	-86%	-$5.37M	0.15%	95
2023 Q2	$6.53M	Sell	102,057 -69,009	-40%	-$4.63M	1.19%	30
2023 Q1	$11.9M	Sell	171,066 -9,680	-5%	-$683K	2.3%	14
2022 Q4	$13M	Buy	180,746 +4,163	+2%	+$314K	2.69%	11
2022 Q3	$12.6M	Sell	176,583 -16,879	-9%	-$1.22M	2.71%	11
2022 Q2	$14.9M	Sell	193,462 -9,732	-5%	-$741K	3.17%	6
2022 Q1	$14.8M	Buy	203,194 +7,910	+4%	+$531K	2.41%	13
2021 Q4	$12.2M	Buy	195,284 +9,824	+5%	+$576K	1.95%	14
2021 Q3	$11M	Buy	185,460 +145,335	+362%	+$9.57M	2.21%	18
2021 Q2	$2.68M	Buy	40,125 +1,954	+5%	+$127K	0.65%	42
2021 Q1	$2.41M	Buy	+38,171	New	+$2.37M	0.64%	41
2018 Q4	–	Sell	-5,384	Closed	-$334K	–	79
2018 Q3	$334K	Sell	5,384 -5,616	-51%	-$333K	0.09%	75
2018 Q2	$609K	Sell	11,000 -44,749	-80%	-$2.42M	0.2%	63
2018 Q1	$3.53M	Buy	55,749 +12,832	+30%	+$825K	1.73%	19
2017 Q4	$2.63M	Buy	+42,917	New	+$2.68M	1.13%	28

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Stansberry Asset Management's BMY Position: Q4 2023 in Review

Stansberry Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 14,472 shares — an estimated $840K sold.

Stansberry Asset Management first reported a position in BMY in Q4 2017 and held it in 15 quarters. The position peaked at $14.9M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Stansberry Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Stansberry Asset Management sold 14,472 Bristol-Myers Squibb shares in Q4 2023, an estimated $840K.
Stansberry Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 15 quarters.
Stansberry Asset Management's Bristol-Myers Squibb position peaked at $14.9M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Stansberry Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.